A study of enzymes involved in catecholamine metabolism in parents of patients with schizophrenia

Schizophrenia Research

Volumn 19, Issue 1, 1996, Pages 27-32

  Wei, Jun ^a   Ramchand, C N ^a   Clark, Anne E ^a   Hemmings, Gwynneth P ^a  

^a Institute of Biological Psychiatry   (United Kingdom)

Author keywords

Amino acid; Catecholamine; Inheritance of schizophrenia

Indexed keywords

AMINE OXIDASE (FLAVIN CONTAINING); CATECHOL METHYLTRANSFERASE; CATECHOLAMINE; DOPAMINE BETA MONOOXYGENASE; ENZYME; HOMOVANILLIC ACID; NORADRENALIN; PHENYLALANINE; TYROSINE;

ADULT; AGED; ALLELE; ARTICLE; CATECHOLAMINE METABOLISM; ENZYME ACTIVITY; ERYTHROCYTE; FEMALE; HUMAN; HUMAN EXPERIMENT; INHERITANCE; MALE; NORMAL HUMAN; PARENT; PRIORITY JOURNAL; SCHIZOPHRENIA; SERUM; THROMBOCYTE;

EID: 0029880946     PISSN: 09209964     EISSN: None     Source Type: Journal    
DOI: 10.1016/0920-9964(95)00044-5     Document Type: Article

References (41)

1. Baron, M. (1986) Genetics of schizophrenia: I. Familial patterns and mode of inheritance. Biol. Psychiatry 21, 1051-1066.
2. Bondy, B., Ackeneil, M., Birzle, W., Eibers, R. and Frohler, M. (1984) Catecholamines and their receptors in blood: Evidence for alterations in schizophrenia. Biol. Psychiatry 19, 1377-1993.
3. Breier, A., Wolkowitz, O.M., Roy, A., Potter, W.Z. and Pickar, D. (1990) Plasma norepinephrine in chronic schizophrenia. Am. J. Psychiatry 147, 1467-1470.
4. Bowers, M.B., JR., Swigar, M.E., Jatlow, P.I. and Goicoechea, N. (1984) Plasma catecholamine metabolites and early response to haloperidol. J. Clin. Psychiatry 45, 248-251.
5. Castellani, S., Ziegler, M.G., Van Kammen, D.P., Alexander, P.E., Siris, S.G. and Lake, C.R. (1982) Plasma norepinephrine and dopamine β-hydroxylase activity in schizophrenia. Arch. Gen. Psychiatry 39, 1145-1149.
6. Chang, W-H., Chen, T-Y., Lin, S-K., Lung, F-W., Lin, W-L., Hu, W-H. and Yeh, E-K. (1990) Plasma catecholamine metabolites in schizophrenics: Evidence for the two-subtype concept. Biol. Psychiatry 27, 510-518.
7. Chen, T-Y., Lee, C-F., Lung, F-W., Lee, T-C., Lin, W-L., Hu, W-H., Yeh, E-K. and Chang, W-H. (1989) Plasma homovanillic acid in schizophrenics: Supportive evidence for the two-subtype hypothesis. J. Formosan Med. Assoc. 88, 584-588.
8. Davidson, M. and Davis, K.L. (1988) A comparison of plasma homovanillic acid concentrations in schizophrenic patients and normal controls. Arch. Gen. Psychiatry 45, 561-563.
9. Farley, I.J., Price, K.S., McCullough, E., Deck, J.H., Hordynski, W. and Hornykiewicz, O. (1978) Norepinephrine in chronic paranoid schizophrenia: Above-normal levels in limbic forebrain. Science 200, 456-458.
10. Freedman, R., Kirch, D., Bell, J., Adler, L.E., Pecevish, M., Pachtman, E. and Denver, P. (1982) Clonidine treatment of schizophrenia. Acta Psychiat. Scand. 65, 35-45.
11. Gershon, E.S. and Jonas, W.Z. (1975) A clinical and genetic study of erythrocyte catechol-O-methyltransferase activity in primary affective disorder. Arch. Gen. Psychiatry 32, 1352-1356.
12. Gottesman, I.I. and Bertelsen, A. (1989) Confirming unexpressed genotypes for schizophrenia. Arch. Gen. Psychiatry 46, 867-872.
13. Heston, I.L. and Denney, D. (1968) Interactions between early life experience and biological factors in schizophrenia. In D. Rosenthal and S. Kety (Eds), The Transmission of Schizophrenia. Pergamon Press, Oxford, pp. 363-378.
14. Hornykiewicz, O. (1982) Brain catecholamines in schizophrenia-a good case for noradrenaline. Nature 299, 484-486.
15. Hornykiewicz, O. (1986) Brain noradrenaline and schizophrenia. In J.M. van Ree and S. Matthysse (Eds), Progress in Brain Research, Vol. 65, Elsevier, Amsterdam, pp. 29-39.
16. Karlsson, J.L. (1982) Family transmission of schizophrenia: A review and synthesis. Br. J. Psychiatry 140, 600-606.
17. Kaufman, S. (1970) A protein that stimulates rat liver phenylalanine hydroxylase. J. Biol. Chemistry 245, 4751-4759.
18. Kemali, D., Del Vecchio, M. and Maj, M. (1982) Increased noradrenaline levels on CSF and plasma of schizophrenic patients. Biol. Psychiatry 17, 711-717.
19. Kety, S.S. (1983) Mental illness in the biological and adoptive relatives of schizophrenic adoptees: Findings relevant to genetic and environmental factors in etiology. Am. J. Psychiatry 140, 720-727.
20. Lake, C.R., Sternberg, D.E., Van Kammen, D.P., Ballenger, J.C., Ziegler, M.G., Post, R.M., Kopin, I.J. and Bunney, W.E. (1980) Schizophrenia: Elevated cerebrospinal fluid norepinephrine. Science 207, 331-333.
21. Letemendia, F.J.J. and Harris, A.D. (1967) Chlorpromazine and the untreated chronic schizophrenics: A long-term trial. Br. J. Psychiatry 113, 950-958.
22. Matthysse, S. and Baldessarini, J. (1972) S-adenosylmethionine and catechol-O-methyltransferase in schizophrenia. Am. J. Psychiatry 128, 10.
23. Murphy, D.L., Wright, C., Buchsbaum, M., Nichols, A., Costa, J.L. and Wyatt, R.J. (1976) Platelet and plasma amine oxidase activity in 680 normals: Sex and age differences and stability over time. Biochem. Med. 16, 254-265.
24. Murphy, D.L. and Wyatt, R.J. (1972) Reduced monoamine oxidase activity in blood platelets from schizophrenic patients. Nature 238, 225-226.
25. Nagatsu, T., and Udenfried, S. (1972). Photometric assay of dopamine-β-hydroxylase activity in human blood. Clin. Chemistry 18, 980-983.
26. Nies, A., Robinson, D.S., Lamborn, K.R. and Lampert, R.P. (1973) Genetic control of platelet and plasma monoamine oxidase activity. Arch. Gen. Psychiatry 28, 834-838.
27. Perry, T.L., Hansen, J., Tischler, B., Richards, F.M. and Sokol, M. (1973) Unrecognised adult phenylketonuria: Implications for obstetrics and psychiatry. N. Eng. J. Med. 289, 395-398.
28. Rice, J., McGuffin, P., Goldin, L., Shaskan, E.G. and Gershon, E.S. (1984) Platelet monoamine oxidase (MAO) activity: Evidence for a single major locus. Am. J. Hum. Genet. 36, 36-43.
29. Sedvall, G.C., Fryo, B., Gullberg, B., Nyback, H., Wiesel, F-A. and Wode-Helgodt, B. (1980) Relationships in healthy volunteers between concentrations of monoamine metabolites in cerebrospinal fluid and family history of psychiatric morbidity. Br. J. Psychiatry 136, 366-374.
30. Sedvall, G.C. and Wode-Helgodt, B. (1980). Aberrant monoamine metabolite levels in CSF and family history of schizophrenia. Arch. Gen. Psychiatry 37, 1113-1116.
31. Stein, L. and Wise, C.D. (1971) Possible etiology of schizophrenia: Progressive damage to the noradrenergic reward system by 6-hydroxydopamine. Science 171, 1032-1036.
32. Tsuang, M.T., Winokur, G. and Crowe, R.R. (1980) Morbidity risks of schizophrenia and affective disorders among first degree relatives of patients with schizophrenia, mania, depression, and surgical conditions. Br. J. Psychiatry 137, 497-504.
33. Van Kammen, D.P., Mann, L.S., Sternberg, D.E., Scheinin, M., Ninan, P.T., Marder, S.R., Van Kammen, W.B., Rieder, R.O. and Linnoila, M. (1983) Dopamine-β-hydroxylase activity and homovanillic acid in spinal fluid of schizophrenics with brain atrophy. Science 220, 974-977.
34. Van Kammen D.P., Peters, J.L., Van Kammen, W.B., Rosen, J., Yao, J.K., Mcadam, D. and Linnoila, M. (1989) Clonidine treatment of schizophrenia: Can we predict treatment response? Psychiat. Res. 27, 297-312.
35. Van Kammen, D.P., Van Kammen, W.B., Mann, L.S., Seppala, T. and Linnoila, M. (1986) Dopamine metabolism in the cerebrospinal fluid of drug-free schizophrenic patients with and without cortical atrophy. Arch. Gen. Psychiatry 43, 978-983.
36. Wei, J., Ramchand, C.N., and Hemmings, G.P. (1992). Studies on concentrations of NA and HVA and activity of DBH in the serum from schizophrenic patients, first-degree relatives and normal subjects. Schizophr. Res. 8, 103-110.
37. Wei, J., Xu, H-M., and Hemmings, G.P. (1993). Studies on neurochemical heterogeneity in healthy parents of schizophrenic patients. Schizophr. Res. 10, 173-178.
38. Weinshilboum, R.M. (1983). Biochemical genetics of catecholamines in humans. Mayo Clin. Proc. 58, 319-330.
39. Wise, C.D., Baden, M.M. and Stein, L. (1975) Postmortem measurement of enzymes in human brain: Evidence of a central noradrenergic deficit in schizophrenia. J. Psychiat. Res. 11, 185-198.
40. Wyatt, R.J., Murphy, D.L., Belmaker, R., Cohen, S., Donnelly, C.H. and Pollin, W. (1973) Reduced monoamine oxidase activity in platelets: A possible genetic marker for vulnerability to schizophrenia. Science 179, 916-918.
41. Yorkston, N.J., Zaki, S.A., Malik, M.K.U., Morrison, R.C. and Havard, C.W.H. (1974) Propranolol in the control of schizophrenic symptoms. Br. Med. J. 4, 633-635.